Draghia-Akli Ruxandra bought NVAX
November 11, 2025 · Form 4 insider transaction
Draghia-Akli Ruxandra bought 14,257 shares of Novavax, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
14,257
Price
$0.00
Total value
N/A
InsiderDraghia-Akli Ruxandra
RoleOfficer
CompanyNovavax, Inc. (NVAX)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateNovember 11, 2025
Filing dateNovember 13, 2025
Shares owned after14,257
OwnershipDirect
10b5-1 planNo
AmendedNo